K. Shiraki

Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan

T. Takeuchi, T. Yoshiyasu, K. Ishida, 2018, Modern rheumatology.

Splenic Hemangiosarcoma in a Young Sprague-Dawley Rat

M. Ono, Y. Oishi, K. Shiraki, 2012, Journal of toxicologic pathology.

Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus

T. Yoshiyasu, K. Ishida, K. Shiraki, 2015, Drugs in R&D.

Spontaneously Occurring Subcutaneous Tissue Sarcoma in a Sprague-Dawley Rat

Kyoko Ito, M. Ono, K. Shiraki, 2007 .

THU0206 Post-Marketing Surveillance of Efficacy and Safety of Tacrolimus Add-on Therapy in Japanese Rheumatoid Arthritis Patients without An Adequate Response To Biological dMARDs

T. Takeuchi, T. Yoshiyasu, K. Ishida, 2016 .

Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice.

D. Nakae, K. Miyajima, A. Maekawa, 1999, Cancer letters.

[18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity.

A. Fujikawa, M. Fujiwara, S. Miyoshi, 2013, Toxicological sciences : an official journal of the Society of Toxicology.

Transitional Gene Expression Profiling in Ovarian Follicle during Ovulation in Normal-Cycle Rats

Masayuki Kanki, H. Nakayama, J. Seki, 2011, Toxicologic pathology.

A Uterine Choriocarcinoma in a Virgin Donryu Rat

Midori Yoshida, A. Maekawa, Masakazu Takahashi, 1997, Toxicologic pathology.

Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.

M. Shibasaki, M. Hayakawa, K. Shiraki, 2009, Metabolism: clinical and experimental.